Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Mereo Biopharma Group Fundamentals

Company Name Mereo BioPharma Last Updated 04 Jun 2020
Industry Health Care Sector Biotechnology
Shares in Issue (m) 124.51 Market Cap (£m) 61.63
PE Ratio -1.10 Div per Share () 0.00
Div Yield 0.00 Div Cover 0.00
EPS -45.00 EPS Growth (%) 19.64
PEG -0.06 DPS Growth (%) n/a
Debt Ratio 35.87 Debt Equity Ratio 0.53
Net Gearing 14.07 Gross Gearing 51.29
Asset Equity Ratio 2.05 Cash Equity Ratio 76.42
Quick Ratio 2.13 Current Ratio 2.13
Price To Book Value 1.88 ROCE -73.01

Mereo Biopharma Group Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total

Mereo Biopharma Group Company Financials

Assets (£m) 2018 2017 2016
Tangible Assets 0 0 0
Intangible Assets 33 33 26
Investments 0 0 0
Total Fixed Assets 33 33 26
Stocks 0 0 0
Debtors 1 2 2
Cash & Equivalents 25 50 54
Other Assets 9 11 5
Total Assets 67 96 87
Liabilities (£m) 2018 2017 2016
Creditors within 1 year 16 10 3
Creditors after 1 year 18 24 4
Other Liabilities 0 0 0
Total Liabilities 35 34 8
Net assets 33 62 79
Equity (£m) 2018 2017 2016
Called up share capital 0 0 0
Share Premium 118 118 100
Profit / Loss -37 -47 -34
Other Equity 25 23 13
Preference & Minorities 0 0 0
Total Capital Employed 33 62 79
Ratios 2018 2017 2016
Debt Ratio 35.87 27.95 5.15
Debt-to-Equity 0.53 0.72 0.57
Net Gearing 14.07 -16.81 -53.10
Gross Gearing 51.29 35.14 8.65
Assets / Equity 2.05 1.54 1.10
Cash / Equity 76.42 80.09 67.60
EPS -45.00 -56.00 -63.00
Cash Flow (£m) 2018 2017 2016
Cash from operating activities -23 -32 -27
Cashflow before financing -23 -36 -27
Increase in Cash -25 -2 41
Income (£m) 2018 2017 2016
Turnover 0 0 0
Cost of sales 0 0 0
Gross Profit 0 0 0
Operating Profit -35 -45 -36
Pre-Tax profit -37 -47 -34
Profit / Loss for the year 0 0 0

Mereo Biopharma Group Company Background

Sector Biotechnology
Activities Mereo BioPharma Group plc is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for patients with rare diseases. Mereo's strategy is to selectively acquire product candidates that have substantial preclinical, clinical and manufacturing data packages. Mereo's four product candidates have previously generated positive clinical data for Mereo's target indications or in related indications. Mereo has commenced randomized Phase 2 clinical trials for all four of the product candidates. In connection with the merger with OncoMed, Mereo added two candidates to its pipeline, Navicixizumab and Etigilimab.
Latest Interim Date 17 Sep 2019
Latest Fiscal Year End Date 29 Apr 2019

Mereo Biopharma Group Directors

Appointed Director Position
10 Mar 2015 Denise Vera Scots-Knight Chief Executive Officer
30 Jan 2017 Richard Crispin Morgan Jones Chief Financial Officer
29 Jul 2015 Dr Peter John Fellner Non-Executive Chairman
21 Apr 2015 Kunal Kashyap Non-Executive Director
21 Apr 2015 Anders Ekblom Non-Executive Director
06 Oct 2015 Paul Blackburn Non-Executive Director
21 Apr 2015 Peter James Jonathan Bains Non-Executive Director

Mereo Biopharma Group Contact Details

Company Name Mereo BioPharma
Company Address 1 Cavendish Place, London W1G 0QF.
Company Telephone +44 (0)333 0237 300
Company Website http://www.mereobiopharma.com/

Mereo Biopharma Group Advisors

Auditor Name Ernst & Young LLP
Auditor Address 1 More London Place, London SE1 2AF.
Auditor Website http://www.ey.com/
Auditor Telephone +44 (0)20 7951 2000
Registrar Name Link Asset Services
Registrar Address The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU.
Registrar Website http://www.linkassetservices.com/
Registrar Telephone 0870 162 3100
Broker Name Cantor Fitzgerald Europe
Broker Address 17 Crosswall, London E14 5RD.
Broker Website http://www.cantor.com/
Broker Telephone +44(0)20 7894 7000
Adviser Name Cantor Fitzgerald Europe
Adviser Address 17 Crosswall, London E14 5RD.
Adviser Website http://www.cantor.com/
Adviser Telephone +44(0)20 7894 7000
Solicitor Name Proskauer Rose (UK)
Solicitor Address Heron Tower, 110 Bishopsgate, London EC2N 4AY
Solicitor Website http://www.proskauer.com/
Solicitor Telephone +44 (0)20 7280 2000
Stockbroker Name n/a
Stockbroker Address n/a
Stockbroker Website n/a
Stockbroker Telephone n/a